Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
Date:11/8/2010

ed43,21437,31039,97032,578(1) Includes non-cash share-based expenses of $495 and $584 or approximately $0.01 and $0.02 effect on basic and diluted net loss per common share for the three months ended September 30, 2010 and 2009, respectively. Research and development expense and general and administrative expense includes $206 and $289, respectively, of non-cash share-based expenses for the three months ended September 30, 2010. Research and development expense and general and administrative expense includes $287 and $297, respectively, of non-cash share-based expenses for the three months ended September 30, 2009. Includes non-cash share-based expenses of $1,457 and $2,330 or approximately $0.04 and $0.07 effect on basic and diluted net loss per common share for the nine months ended September 30, 2010 and 2009, respectively. Research and development expense and general and administrative expense includes $643 and $814, respectively, of non-cash share-based expenses for the nine months ended September 30, 2010. Research and development expense and general and administrative expense includes $1,230 and $1,100, respectively, of non-cash share-based expenses for the nine months ended September 30, 2009.Anadys Pharmaceuticals, Inc.Condensed Consolidated Balance Sheets(In thousands)September 30,December 31,20102009(Unaudited)(Audited)AssetsCash, cash equivalents and securities available-for-sale$

18,915$

20,490Other current assets854559Noncurrent assets325686Total assets$

20,094$

21,735Liabilities and Stockholders' EquityCurrent liabilities$

2,751$

3,383Common stock warrant liability3,9103,897Other long-term liabilities1726Stockholders' equity13,41614,429Total liabilities and stockholders' equity$

20,094$

21,735Pegasys® and Copegus® are registered trademarks of Hoffman-La Roche Inc.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... New York , July 11, 2014 ... by Transparency Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic ... Size, Share, Growth, Trends and Forecast, 2013-2019" the global ... in 2012 and is expected to grow at a ... an estimated value of USD 36.9 billion in 2019. ...
(Date:7/10/2014)... , July 11, 2014  Major advances in ... cancer are being highlighted in a three-day Oncology ... from 10-12 July, 2014.  Renowned national and international cancer ... best practices and exchange knowledge on modern technologies ... and efficient. The Summit will ...
(Date:7/10/2014)... , July 10, 2014  RESMED INC. (NYSE: ... fourth quarter and fiscal year ended June 30, 2014 results ... Exchange market close. A press release with ResMed,s results will ... company will host a webcast to discuss operating results and ... begin at 1:30 p.m. US Pacific Time and the live ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... USA, Inc., an international specialty pharmaceutical company, announced today ... accepted for review the New Drug Application (NDA) for ... medication for the treatment of Alzheimer,s disease. ... a license agreement executed between Teikoku Pharma USA, Inc. ...
... SILVER SPRING, Md., Sept. 17 The U.S. Food ... safety review of the diabetes drug Actos (pioglitazone), after ... to evaluate the risk of bladder cancer associated with ... ) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ...
Cached Medicine Technology:FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA for Review 2FDA Reviewing Preliminary Safety Information on Actos (pioglitazone) 2
(Date:7/12/2014)... 12, 2014 Wright & Schulte LLC has ... , Inc., a subsidiary of Johnson & Johnson, on behalf ... pain after receiving a metal-on-metal DePuy Pinnacle hip replacement and ... the artificial hip implant. The DePuy hip lawsuit was filed ... of Texas (Case No. 3:14-cv-2427) where DePuy Pinnacle Hip ...
(Date:7/12/2014)... City, Utah (PRWEB) July 12, 2014 ... two types of startups, with awards being bestowed to ... emphasis spotlighted Utah’s outstanding entrepreneur community with recognition for ... a sustainable model with incoming revenue. , 25 Under ... across the state that are under 5 years old. ...
(Date:7/12/2014)... 12, 2014 Wright & Schulte LLC, an ... Just For Men Lawsuits (case #59776/2014), announces they have ... reports that allege the popular hair dye, Just For Men, ... their face, neck and other areas. In addition to detailing ... chemical burns , the advertisements being run by Wright & ...
(Date:7/12/2014)... The largest pure occupational medicine company in ... that it will be opening its fifth Georgia center ... four Atlanta-based Nova Medical Centers’ locations. The Augusta ... Road, and will be open from 8:30 a.m. to ... treatment philosophy of rapid return-to-work and decreased treatment times ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The American ... America’s 55 poison centers are commending Senator Bill Nelson ... Prevention Act of 2014 on July 10, 2014. Along ... Consumer Products Safety Commission (CPSC) to enact rules requiring ... consumers. , Senate co-sponsors of the bill ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 2Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 3Health News:Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns 4Health News:Nova Medical Centers To Open New Facility in Augusta, Georgia 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 3
... alcohol produces pathological alterations in the brain. In ... deterioration and disorders of memory and learning. Severe ... drinkers. Alcoholic dementia is the second leading course ... for 10% of the cases, and still represents ...
... Now Technology Partner of Choice for Nearly 20 North ... Providers and Local Management Entities ... Technologies, Inc.,a leading provider of enterprise-wide software and services ... signed a contract with,Wake County, North Carolina, to provide ...
... from Scott P. Serota, President and CEO Blue Cross ... P. Serota,president and chief executive officer of the Blue ... in response to the launch,of a new healthcare coalition, ... Blue Shield Association agrees strongly with the,Health Care America ...
... cigarette smoking accounts for up to half of all bladder ... including more than three-quarters of patients who have bladder cancer, ... Comprehensive Cancer Center. , This knowledge vacuum suggests that urologists ... of telling patients about the risk of smoking and encourage ...
... 8 , WHAT: City of Hope and ... Gota de la Vida campaign to support City ... for cancer and other,life-threatening diseases. The campaign will ... Marrow Registry. This year,s activities,will include public service ...
... CONSHOHOCKEN, Pa., July 8 Wolters Kluwer Health, ... information and business,intelligence for students, professionals, and institutions ... industry, announced,today the appointment of Susan Driscoll as ... division of its Professional & Education,business unit., ...
Cached Medicine News:Health News:Netsmart Technologies Selected by Wake County, N.C. to Provide Behavioral Healthcare Software and Implementation Services 2Health News:Netsmart Technologies Selected by Wake County, N.C. to Provide Behavioral Healthcare Software and Implementation Services 3Health News:Blue Cross and Blue Shield Association Statement: Health Care America Now 2Health News:Patients unaware of link between smoking and bladder cancer 2Health News:Paul Rodriguez, Voces Del Rancho and More to Be Honored at the 8th Annual Angels of Hope Awards, July 12 2Health News:Wolters Kluwer Health Appoints Susan Driscoll as Executive Vice President & General Manager of the Books Business of its Professional & Education Unit 2Health News:Wolters Kluwer Health Appoints Susan Driscoll as Executive Vice President & General Manager of the Books Business of its Professional & Education Unit 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: